Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases - Wakabayashi, T; Oshima, Y; Sakaguchi, H (Ophthalmology, 2008)
et al.